OBJECTIVES: Previous studies looking at the influence of positive circumferential margin (CRM) on survival after oesophagectomy are conflicting. This may be due to the fact that older versions of the TNM classification were used, which do not predict survival as accurately as the new 7th edition. We examine whether CRM involvement has an impact on survival when the 7th TNM classification is used.
INTRODUCTION
Oesophageal cancer is an aggressive neoplasm with poor prognosis. It is the eighth most common cancer worldwide and the sixth leading cause of death from cancer [1] . A number of studies from different centres have given conflicting results regarding the correlation between circumferential margin (CRM) and survival [2, 3] . A recent best-evidence topic suggested that the role of CRM as a predictor of survival is unclear; however, for patients who underwent neo-adjuvant chemotherapy, there appears to be emerging evidence supporting the concept that CRM involvement is an independent predictor of poor long-term outcome [4, 5] .
There has been a recent trend towards better surgical outcomes due to better patient selection, new staging modalities and the availability of neo-adjuvant chemotherapy [6, 7] . These advances are based on better understanding of the correlation between histopathological characteristics, long-term survival and local recurrence [8, 9] . These recent trends are the basis of the revision of the old 6th TNM classification of oesophageal cancer and the introduction of the 7th edition in 2010 [10 -12] . Some discrepancies exist in the definition of CRM in the R0 and R1 categories between the College of American Pathologist (CAP) and the Royal College of Pathologist (RCP) [13] . While the RCP adopts a more aggressive definition of CRM involving tumour within 1 mm of the cut margin, the CAP considers a positive resection margin involved only when the tumour is at the cut edge.
The purpose of our study was to identify whether the involvement of the CRM margin in T3 oesophageal cancer patients has an impact on survival when the new 7th edition of TNM classification is applied. between 1 January 2000 and 31 December 2010 at the Liverpool Heart & Chest Hospital. Preoperative data and operative data were collected during patient admission as part of routine clinical practice. Postoperative data were entered on hospital discharge when the final postoperative histology report was available. Up-to-date survival data were obtained from the National Strategic Tracing Service.
Surgical technique
Full preoperative assessment was performed at the specialist oesophageal outpatient clinic. Tumour staging was done using endo-oesophageal ultrasound, CT-scan of the chest, abdomen and pelvis, and in the latter half of the study period, positron emission tomography of the whole body. Routine blood and pulmonary function tests were performed in all patients. Patients who were considered fit enough to tolerate chemotherapy and who had T2, T3 or suspected node-positive disease received neo-adjuvant cisplatinum-based chemotherapy.
Oesophagectomy was performed by either an Ivor-Lewis or a left thoracoabdominal approach for mid-to lower oesophageal tumours (168/199). A three-stage McKeown procedure was used for tumours in the upper third of the oesophagus (31/199).
Macroscopic circumferential margins (CRMs) were obtained by removing pleural, diaphragm, lung or aortic adventitia where necessary. If it was not possible to achieve a macroscopic CRM the patient was closed and referred for radiotherapy. A proximal resection margin of at least 5 cm and distal margin of at least 3 cm were obtained.
Postoperative patient care included extubation in the operating room, pain control via epidural analgesia, vigorous respiratory physiotherapy and early mobilization. Oral intake was commenced on postoperative days 4-7 (according to surgeon preference). No patient deemed to have CRM involvement underwent adjuvant treatment.
Tissue and specimen handling
Resected specimens were handled according to the Royal College of Pathologists manual guidance [14] . Specimens were pinned to a cork board before fixation with 10% neutral buffered formalin and, if the oesophagus was opened at this stage, the outer aspect was painted. Dissection, sampling and histological reporting were then performed according to the dataset and pathological staging following the International Union against Cancer (UICC) TNM staging system at the time and later revised according to the TNM-7th edition [15] . The CRM was assessed from tissue blocks taken through the wall at the base of the tumour. It is said to be 'Involved' when tumour has grown to within 1 mm of it, as assessed microscopically.
Statistical methods
Differences in case-mix were assessed for statistical significance using χ 2 methodology or Kruskal-Wallis tests as appropriate. In order to develop a multivariate model for survival in these patients, initially each of the variables listed in Table 1 was assessed for effect on survival using a univariate Cox regression. When potentially significant predictors (P < 0.1) were identified in the univariate analysis, they were then integrated into a forward stepwise Cox regression model. They were allowed to remain in the final model if a P-value of <0.05 was achieved. The Kaplan-Meier survival curve has been performed for both the groups (see Fig. 1 ).
RESULTS
Eighty-six patients were excluded from the study as they did not have pathological stage T3. Of the 199 patients remaining in the study population with pathological stage T3, 139 were males (69.4%) and 63 (31.6%) were females. The mean age of the patients was 66.5 (range 59-72). Of note, 151 of these patients (76%) were found to have CRM involvement (<1 mm) and were compared with 48 patients in whom the CRM was free of tumour (24%). The mean follow-up was 4 years (range 1-10 years).
The patient characteristics, histological characteristics and lymph node stage of each group are given in Table 1 . Histology was adenocarcinoma in 141 patients (70.85%), squamous cell carcinoma in 54 (27.13%) and mixed adeno-squamous in 4 (2.02%). Table 2 show a univariate survival analysis of the study patient characteristics including the P-values for each parameter and its hazard ratio (HR).
Following multivariate analysis, CRM involvement was found not to be a predictor of survival following resection of T3 oesophageal tumours [HR 1.28 (95% CI: 0.82-2.01) (P = 0.28)]. The only significant predictors were found to be 'stage of disease, age at operation, shortness of breath (according to NYHA classification) and % predicted FEV1' (Table 3) .
We believed that a positive CRM may have more of an influence on survival in patients with a lower N-stage; therefore, a sub-group analysis was performed. The sub-group analyses confirmed that CRM involvement did not have any association with survival for any N-stage of disease Table 1 .
Neo-adjuvant chemotherapy was used in 118 patients (59.29%). Patients who underwent neo-adjuvant chemotherapy were less likely to have CRM involvement (78.3 vs 56.9% P < 0.01). We analysed the effect of the neo-adjuvant chemotherapy on survival when the CRM was positive or negative using Kaplan-Meier methods. We found no statistically significant difference in survival between the groups. However, the numbers of patients in the 'CRM not involved' groups was too small to reach meaningful conclusions.
DISCUSSION
Surgery alone or in combination with other treatment modalities has proven to be the best potential curative option for oesophageal cancer [16, 17] . However, the general outcome following surgical resection is poor with high local tumour recurrence rates [18] . Established independent prognostic factors after resection have been already identified such as tumour stage, grade, nodal involvement, lymph node ratio and tumour infiltration of the proximal or distal resection margin. There have been a number of studies that have investigated the prognostic value of CRM involvement. These have produced conflicting results [19] . In this study, we investigated this question by restaging our patients using the new 7th edition TNM classification, as we believe this is a more accurate predictor of survival than previous versions. The CRM involvement was not found to be an Over the last two decades, there has been a debate over the significance of circumferential resection margins (CRM) involvement and its place as a prognostic indicator. Skinner et al. [20] started to take into consideration the relation of the CRM margin with outcome in 1982 and Sagar et al. [2] following this idea, established a link after reviewing the fact that in breast and rectal cancers the role of CRM involvement had a significant impact on the outcomes. A number of studies have investigated this hypothesis; however, the results have differed [21] .
Although some adjacent structures such as pleura, aortic adventitia, diaphragm and lung may be removed to obtain clear CRM, many of the radial boundaries of the oesophagus are adjacent to the pleural space where a lack of gross tumour involvement of adjacent structures precludes any true positive radial margin.
Khan et al. [4] , in a best evidence topic, summarized seven studies that showed conflicting results regarding the correlation of CRM involvement and prognosis. As this paper suggested, these studies with different designs and operative techniques and only a few patients having neo-adjuvant chemotherapy make these results difficult to interpret.
In order to assess better the CRM involvement as a prognostic index, we used the new 7th TNM edition as the old TNM classification had a number of drawbacks, particularly with regards to lymph node staging. This new classification is based on risk-adjusted random forest analysis of worldwide data. It accounts for interactions of anatomical and non-anatomical cancer characteristics [22] [23] [24] . One would expect that after using this accurate new classification, one would be able to determine better whether a positive involvement of the CRM is a predictor of outcome.
Preoperative chemotherapy based on Cisplatin has been used in more than half of our patients (59%). The rest were not clinically suitable due to their age and fitness status. The number of patients receiving neo-adjuvant chemotherapy was greater in the no-CRM-involvement group. We believe that this was due to the effect of down-staging by neo-adjuvant chemotherapy rather than the groups not being evenly matched. We found that no statistically significant difference in survival in either the CRM involved-or not-involved groups with neo-adjuvant chemotherapy. However, the numbers of patients in each group are probably too small to reach meaningful conclusions.
We acknowledge that our study has some limitations: as a UK institution the pathological staging we used was the RCP, as did most of the studies from the UK. A number of studies using the CAP histological interpretation have different results from those of UK centres [25] . It is impossible for us to tell whether our results would have differed if we had used the CAP histological interpretation.
We conclude from this study that despite using the 7th TNM classification, CRM involvement does not affect long-term survival of patients after oesophagectomy and therefore patients with CRM involvement should not necessarily be classified as having an incomplete resection.
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